Trial Profile
Effect of co-administration of Olmesartan and Azelnidipine on vascular endothelial function in patients with atherosclerosis-prone conditions.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2012
Price :
$35
*
At a glance
- Drugs Azelnidipine (Primary) ; Olmesartan medoxomil (Primary) ; Amlodipine; Valsartan
- Indications Cardiovascular disorders; Hypertension
- Focus Pharmacodynamics
- 05 Dec 2012 New trial record